XTAE
YBRD
Oct 26, Last price
513.80ILS
1D
-0.75%
Jan 2017
-93.73%
Name
Direct Capital Investments Ltd
Chart & performance
P/E
—
P/S
—
EPS
Vol. 1Y
45.31%
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
Net income
CFO
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Key people
Ran Amir
Chief Executive Officer, Director · since 2018
Co-Chief Executive Officer · since 2018
Adi Noyfeld
Vice President - Finance · since 2018
Steven Zeev Eitan
Vice President-Strategy at a Subsidiary (Cannassure Therapeutics) · since 2018
Dana Marom
Vice President-Quality Assurance at a Subsidiary (Cannassure Therapeutics) · since 2018
Hadel Onallah Saad
Vice President-Research & Development at a Subsidiary (Cannassure Therapeutics) · since 2018
Internal Auditor · since 2019
Shimon Bar Kama
Director · since 2019
Abraham Tiber
External Director · since 2007
Valuation
No data to show